Ceramides and other sphingolipids as drivers of cardiovascular disease

RH Choi, SM Tatum, JD Symons… - Nature Reviews …, 2021 - nature.com
Increases in calorie consumption and sedentary lifestyles are fuelling a global pandemic of
cardiometabolic diseases, including coronary artery disease, diabetes mellitus …

Ceramides as novel disease biomarkers

J Kurz, MJ Parnham, G Geisslinger… - Trends in molecular …, 2019 - cell.com
Ceramides are sphingolipids and integral components of the eukaryotic cell membrane.
Apart from providing structural integrity, ceramides have also been shown to act as second …

Dysregulation of lipid metabolism and pathological inflammation in patients with COVID-19

M Caterino, M Gelzo, S Sol, R Fedele, A Annunziata… - Scientific reports, 2021 - nature.com
In recent months, Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) has spread throughout the world. COVID-19 …

Machine learning reveals serum sphingolipids as cholesterol-independent biomarkers of coronary artery disease

AM Poss, JA Maschek, JE Cox… - The Journal of …, 2020 - Am Soc Clin Investig
BACKGROUND Ceramides are sphingolipids that play causative roles in diabetes and heart
disease, with their serum levels measured clinically as biomarkers of cardiovascular disease …

[HTML][HTML] The role of C16: 0 ceramide in the development of obesity and type 2 diabetes: CerS6 inhibition as a novel therapeutic approach

S Raichur, B Brunner, M Bielohuby, G Hansen… - Molecular …, 2019 - Elsevier
Objective Ectopic fat deposition is associated with increased tissue production of ceramides.
Recent genetic mouse studies suggest that specific sphingolipid C16: 0 ceramide produced …

Genome-wide association analysis of plasma lipidome identifies 495 genetic associations

L Ottensmann, R Tabassum, SE Ruotsalainen… - Nature …, 2023 - nature.com
The human plasma lipidome captures risk for cardiometabolic diseases. To discover new
lipid-associated variants and understand the link between lipid species and cardiometabolic …

Suppressing the intestinal farnesoid X receptor/sphingomyelin phosphodiesterase 3 axis decreases atherosclerosis

Q Wu, L Sun, X Hu, X Wang, F Xu… - The Journal of …, 2021 - Am Soc Clin Investig
Intestinal farnesoid X receptor (FXR) signaling is involved in the development of obesity,
fatty liver disease, and type 2 diabetes. However, the role of intestinal FXR in atherosclerosis …

Clinical lipidomics: realizing the potential of lipid profiling

TG Meikle, K Huynh, C Giles, PJ Meikle - Journal of lipid research, 2021 - ASBMB
Dysregulation of lipid metabolism plays a major role in the etiology and sequelae of
inflammatory disorders, cardiometabolic and neurological diseases, and several forms of …

Ceramides as mediators of oxidative stress and inflammation in cardiometabolic disease

M Gaggini, R Ndreu, E Michelucci… - International Journal of …, 2022 - mdpi.com
Ceramides, composed of a sphingosine and a fatty acid, are bioactive lipid molecules
involved in many key cellular pathways (eg, apoptosis, oxidative stress and inflammation) …

The role of smoking in the mechanisms of development of chronic obstructive pulmonary disease and atherosclerosis

S Kotlyarov - International Journal of Molecular Sciences, 2023 - mdpi.com
Tobacco smoking is a major cause of chronic obstructive pulmonary disease (COPD) and
atherosclerotic cardiovascular disease (ASCVD). These diseases share common …